Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation.

MLA

Hobo, W. A., et al. “Improving Dendritic Cell Vaccine Immunogenicity by Silencing PD-1 Ligands Using SiRNA-Lipid Nanoparticles Combined with Antigen MRNA Electroporation.” Cancer Immunology Immunotherapy, 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284132485&authtype=sso&custid=ns315887.

APA

Hobo, W. A., Novobrantseva, T. I., Fredrix, H., Wong, J., Milstein, S., Epstein-Barash, H., Liu, J., Schaap, N. P., Voort, R., & Dolstra, H. (2013). Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation. Cancer Immunology Immunotherapy.

Chicago

Hobo, W.A., T.I. Novobrantseva, H. Fredrix, J. Wong, S. Milstein, H. Epstein-Barash, J. Liu, N.P. Schaap, R. Voort, and H. Dolstra. 2013. “Improving Dendritic Cell Vaccine Immunogenicity by Silencing PD-1 Ligands Using SiRNA-Lipid Nanoparticles Combined with Antigen MRNA Electroporation.” Cancer Immunology Immunotherapy. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1284132485&authtype=sso&custid=ns315887.